Congenital Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Congenital Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy [NA]
A completed clinical trial evaluated a prenatal behavioral intervention aimed at preventing maternal cytomegalovirus infection and congenita…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - CYMEVALIII STEP1 [NA]
A completed clinical trial evaluating prenatal Letermovir versus Valaciclovir for the treatment of congenital cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening [NA]
Clinical trial NCT02139423 has completed and investigated diagnostic methods for congenital cytomegalovirus infection in neonates who failed…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection [Phase 4]
Phase 4 clinical trial evaluating the long-term efficacy of a 4- to 6-month antiviral therapy for neurodevelopmental impairments caused by c…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation [NA]
This completed clinical trial update discusses cytomegalovirus vaccines and challenges related to reinfection and antigenic variation. The s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero [NA]
A completed clinical trial assessing whether neonatal biomarkers can predict neurosensorial sequelae in children with congenital CMV infecti…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir [Phase 4]
This clinical trial update notes the completion of a Phase 4 study investigating in utero treatment of congenital cytomegalovirus infection …
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) [Phase 3]
A Phase 3 trial (PreCyssion) evaluating prevention of maternal-fetal cytomegalovirus transmission after primary maternal infection in early …
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Cytomegalovirus Shedding Characteristics in Pregnant Women
The document notes that a clinical trial studying cytomegalovirus shedding in pregnant women has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) [Phase 3]
A phase 3 randomized trial investigated strategies to prevent congenital cytomegalovirus infection, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Asymptomatic Congenital CMV Treatment [Phase 2]
A Phase 2 trial evaluating treatment for asymptomatic congenital cytomegalovirus infection was terminated; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment [Phase 3]
Phase 3 trial update on antiviral treatment for congenital cytomegalovirus infection with sensorineural hearing loss; study completed.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss [Phase 2]
Phase 2 clinical trial evaluating valganciclovir therapy in infants and children with congenital cytomegalovirus infection and hearing loss …
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance [Phase 2, Phase 3]
Phase 2/3 trial evaluating valganciclovir for reducing CMV-related deafness in congenital CMV infection; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy [Phase 2, Phase 3]
A clinical trial evaluating valacyclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnan…
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Screening for Congenital Cytomegalovirus Infection in Newborns
A clinical trial evaluating screening for congenital cytomegalovirus infection in newborns has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial [Phase 3]
Phase 3 randomized trial evaluating antiviral treatment for congenital cytomegalovirus infection was terminated; the update notes the study …
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections [Phase 3]
Phase 3 trial comparing short-term versus long-term valganciclovir therapy in infants with symptomatic congenital cytomegalovirus infection;…
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: In UTERO Treatment of Cytomegalovirus Congenital Infection With Valacyclovir [Phase 4]
Phase 4 clinical trial evaluating in utero treatment of congenital cytomegalovirus infection with valacyclovir was terminated.
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection [Phase 2, Phase 3]
A Phase 2/3 efficacy study of human cytomegalovirus hyperimmune globulin to prevent congenital cytomegalovirus infection has completed its e…
-
CLINICAL_TRIALS trial_result · 2011-02-07Clinical Trial Update: Valganciclovir in Congenital CMV Infants [Phase 1, Phase 2]
This update indicates a completed Phase 1/2 clinical trial evaluating valganciclovir in infants with congenital cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections. [Phase 3]
A Phase 3 study evaluating the safety and efficacy of ganciclovir (DHPG) for symptomatic central nervous system involvement in congenital cy…
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?
A completed clinical trial evaluating whether normal fetal brain imaging predicts normal neurodevelopment in fetuses with proven cytomegalov…